Clinical analysis by next-generation sequencing for NSCLC patients with MET amplification resistant to osimertinib
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Pulmonary and Respiratory Medicine,Oncology
Reference18 articles.
1. Osimertinib benefit in EGFR-mutant NSCLC patients with T790M-mutation detected by circulating tumour DNA;Remon;Ann. Oncol.,2017
2. Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer;Mok;N. Engl. J. Med.,2017
3. Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M;Thress;Nat. Med.,2015
4. Heterogeneous mechanisms of primary and acquired resistance to third-generation EGFR inhibitors;Ortiz-Cuaran;Clin. Cancer Res.,2016
5. Acquired BRAF V600E mutation as resistant mechanism after treatment with osimertinib;Ho;J. Thorac. Oncol.,2017
Cited by 53 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Liquid biopsy for the management of NSCLC patients under osimertinib treatment;Critical Reviews in Clinical Laboratory Sciences;2024-02-02
2. International expert consensus on diagnosis and treatment of lung cancer complicated by chronic obstructive pulmonary disease;Translational Lung Cancer Research;2023-08
3. Randomized Trial of Tepotinib Plus Gefitinib versus Chemotherapy in EGFR-Mutant NSCLC with EGFR Inhibitor Resistance Due to MET Amplification: INSIGHT Final Analysis;Clinical Cancer Research;2023-03-27
4. Landscape of Savolitinib Development for the Treatment of Non-Small Cell Lung Cancer with MET Alteration—A Narrative Review;Cancers;2022-12-12
5. Overview of the multifaceted resistances toward EGFR-TKIs and new chemotherapeutic strategies in non-small cell lung cancer;Biochemical Pharmacology;2022-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2023 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3